Abstract:Objective: To study the role of miR-124 in myocardial ischemia-reperfusion induced cardiomyocyte injury by targeted regulation of beclin 1 (BECN 1). Method: The rat model of myocardial ischemia-reperfusion was established. The rats were divided into the miR-124 group (injected with miR-124 inhibitor), the MIRI group (not treated), and the miR-NC group (injected with miR-NC). Meanwhile, blank group and sham operation groups were set up. LDH and CK in the five groups were detected by ELISA at 12 h after operation. The myocardial infarct size of each group was measured by multimedia color pathological analysis. Then, an in vitro cell model was established. First, the rat cardiomyocytes were isolated, extracted and cultured; then miR-124 was transfected into the cells, the test group cells were transfected with miR-124, and the miR-NC were transfected into cells. NC cells were set as negative control group, and cells not transfected were set as blank control group. Then, an in vitro cell model was established. First, the rat cardiomyocytes were isolated, extracted and cultured, then cells transfected with miR-124 and miR-NC were set as test group and negative control group, and cells not transfected were set as blank control group. The relative expression of miR-124 in rat myocardium as well as in cardiomyocytes transfected with miR-124 were measured. Western blot was applied to analyze the relative expression levels of Beclin-1 and LC3B proteins in cardiomyocytes and flow cytometry was used to analyze the apoptosis of cells. Results: There were no significant differences in serum CK and LDH levels between the blank group, the sham operation group and the miR-124 group after modeling (P>0.05), but those of the MIRI group and the miR-NC group were significantly higher than that in the blank group, the sham operation group and the miR-124 group (P<0.05). The miR-124 in the myocardial tissue of the blank group, the sham operation group and the miR-124 group were significantly lower than those of the MIRI group and the miR-NC group (P<0.05). There was no significant difference in Beclin 1 mRNA expression among the five groups (P>0.05). The myocardial infarct size of the miR-124 group was significantly smaller than that of the MIRI group and the miR-NC groups (P<0.05). For in vitro results, the expression of miR-124 after transfection in the myocardial cells of the test group was significantly higher than that in the blank group and the negative control group (P<0.05). The expression levels of Bclin 1 and LC3 autophagy in the cardiomyocytes of the test group were significantly lower than those of the blank and negative control groups (P<0.05). The apoptosis rate of cardiomyocytes in the test group was also significantly higher than that in the blank group and the negative control group (P<0.05). Conclusion: miR-124 is highly expressed in MIRI and may reduce the level of autophagy and promote apoptosis through competitive binding of BECN 1, which may be an important target for MIRI treatment in the future.

miR-223 regulates myocardial ischemia-reperfusion damage via targeting NLRP 3 in vitro and in vivo

LINC00511 Accelerates the Proliferation of Cardiomyocytes after Myocardial Ischemia/reperfusion Injury by Absorbing Mirna-515-5p.

MicroRNA-223 alleviates inflammatory response in renal ischemia-reperfusion injury by targeting NLRP3

MicroRNA-223 protects neonatal rat cardiomyocytes and H9c2 cells from hypoxia-induced apoptosis and excessive autophagy via the Akt/mTOR pathway by targeting PARP-1.

Association of MicroRNA-223 Expression with Hepatic Ischemia/Reperfusion Injury in Mice

Inhibition of miR-143-3p alleviates myocardial ischemia reperfusion injury via limiting mitochondria-mediated apoptosis

MiR-129-5p Protects Against Myocardial Ischemia-Reperfusion Injury Via Targeting HMGB1

Absence of miR-223-3p ameliorates hypoxia-induced injury through repressing cardiomyocyte apoptosis and oxidative stress by targeting KLF15.

MiR-302a-3p aggravates myocardial ischemia-reperfusion injury by suppressing mitophagy via targeting FOXO3

Upregulation of miR-223 abrogates NLRP3 inflammasome-mediated pyroptosis to attenuate oxidized low-density lipoprotein (ox-LDL)-induced cell death in human vascular endothelial cells (ECs)

MiR-23a is Involved in Myocardial Ischemia/Reperfusion Injury by Directly Targeting CX43 and Regulating Mitophagy

[MiR-224-5p overexpression inhibits oxidative stress by regulating the PI3K/Akt/FoxO1 axis to attenuate hypoxia/reoxygenation-induced cardiomyocyte injury]

Exsomal microRNA-223 Attenuates Pyroptosis in Renal Ischemia/Reperfusion Injury by Targeting NLR Family Pyrin Domain Containing 3

Inhibiting Mir-205 Alleviates Cardiac Ischemia/Reperfusion Injury by Regulating Oxidative Stress, Mitochondrial Function, and Apoptosis.

miR-451-3p alleviates myocardial ischemia/reperfusion injury by inhibiting MAP1LC3B-mediated autophagy

MiR-138 Ameliorates Myocardial Ischemia/reperfusion Injury by Targeting Intercellular Cell Adhesion Molecule 1

Mir-124 Regulates Myocardial Ischemia Reperfusion Injury

MicroRNA-495 Ameliorates Cardiac Microvascular Endothelial Cell Injury and Inflammatory Reaction by Suppressing the NLRP3 Inflammasome Signaling Pathway

Downregulation Of Mir-34a Attenuates Myocardial Ischemia/Reperfusion Injury By Inhibiting Cardiomyocyte Apoptosis

MicroRNA-133b Alleviates Hypoxia Injury by Direct Targeting on NOD-Like Receptor Protein 3 in Rat H9c2 Cardiomyocyte

ZNF561-AS1 Regulates Cell Proliferation and Apoptosis in Myocardial Infarction Through miR-223-3p/NLRP3 Axis